ÂÜÀòÂÒÂ×

Steve Dubin is currently a principal at SDA Ventures LLC, a firm focused on assisting emerging growth and middle-market companies, primarily in the health, wellness and nutritional products markets. Mr. Dubin is also the former chief executive officer of Martek Biosciences Corporation, a leader in long-chain polyunsaturated (LCPUFA) nutritional products. Mr. Dubin played a key role in developing Martek’s business from an R&D company to a fully integrated, profitable, commercial organization with more than $470 million in annual sales. He served in a variety of positions during 14 years with the company before his election to chief executive officer in July 2006, and served in that capacity until the sale of the company to Royal DSM in 2011 for approximately $1.1 billion. Mr. Dubin holds a B.S. from the University of Maryland, College Park and a J.D. from the National Law Center at the George Washington University.